​

Funding Round

Series C - Frontier Medicines

Series C - Frontier Medicines

Investment Firm

Overview

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Announced Date

Feb 22, 2024

Closed on Date

Feb 22, 2024

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Deerfield Management

Deerfield Management

Deerfield Management is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Droia Ventures

Droia Ventures

Droia Ventures is a early_stage_venture firm.

Participant Investors

6

Investor Name
Participant InvestorDroia Ventures
Participant InvestorRA Capital Management
Participant InvestorDeerfield Management
Participant InvestorGalapagos
Participant InvestorMPM Capital

Round Details and Background

Frontier Medicines raised $80000000 on 2024-02-22 in Series C

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 19, 2021
Series B - Frontier Medicines
10-88.5M
Jul 19, 2019
Series B - Frontier Medicines
6-88.5M
Feb 22, 2024
Series C - Frontier Medicines
6-80.0M
Jun 25, 2024
Series C - Frontier Medicines
2-20.0M

Recent Activity

There is no recent news or activity for this profile.